This company has been marked as potentially delisted and may not be actively trading. DermTech (DMTK) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock DMTK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period DERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJune 10, 2025 | globenewswire.comNorth American Morning Briefing: TSMC Earnings -2-October 18, 2024 | morningstar.comMDermTech, Inc. (DMTKQ)September 27, 2024 | finance.yahoo.comVictory RS Small Cap Growth ASeptember 8, 2024 | morningstar.comMWhy Is DermTech (DMTK) Stock Down 26% Today?June 24, 2024 | investorplace.comDermTech Files for Voluntary Chapter 11 ProtectionJune 18, 2024 | businesswire.comDMTK Stock Earnings: DermTech Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | investorplace.comDermTech GAAP EPS of -$0.58, revenue of $3.85MMay 14, 2024 | msn.comDermTech Reports First-Quarter 2024 Financial ResultsMay 14, 2024 | finance.yahoo.comDermTech stock downgraded by BTIG amid strategic reviewApril 20, 2024 | investing.comBTIG Downgrades DermTech (DMTK)April 19, 2024 | msn.comWhat Analysts Are Saying About DermTech StockApril 19, 2024 | markets.businessinsider.comDermTech to Slash 56% of Workforce, Explore OptionsApril 18, 2024 | marketwatch.comDermTech exploring strategic alternatives, cutting 56% of staffApril 18, 2024 | msn.comDermTech to Explore Strategic Alternatives and Implement Restructuring PlanApril 18, 2024 | businesswire.comDermTech, Inc. (DMTK)April 17, 2024 | finance.yahoo.comDermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative DermatologyMarch 8, 2024 | businesswire.comStephens cuts DermTech stock target to $1.50, keeps Equal Weight ratingMarch 7, 2024 | investing.comDermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call TranscriptMarch 2, 2024 | finance.yahoo.comRecap: DermTech Q4 EarningsFebruary 29, 2024 | benzinga.comDermTech Reports Fourth-Quarter 2023 Financial ResultsFebruary 29, 2024 | businesswire.comDermTech Q4 2023 Earnings PreviewFebruary 28, 2024 | msn.comDermTech Announces Release Date for Fourth-quarter 2023 Financial ResultsFebruary 13, 2024 | finance.yahoo.comDermTech International Registered ShsFebruary 1, 2024 | markets.businessinsider.comDermTech to Cut Workforce by 15%, Six Months After Round of LayoffsJanuary 31, 2024 | marketwatch.comDermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline OperationsJanuary 31, 2024 | finance.yahoo.comDermTech study finds melanoma test effective for all skin typesJanuary 18, 2024 | msn.comDermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin TypesJanuary 18, 2024 | finance.yahoo.comDermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on AssayJanuary 16, 2024 | finance.yahoo.comDermTech Shares Rise 14% After Positive Results in Melanoma Test StudyJanuary 8, 2024 | marketwatch.comDermTech stock rallies 18% on positive study for melanoma testJanuary 8, 2024 | seekingalpha.comDermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)January 8, 2024 | finance.yahoo.comDermTech Stock (NASDAQ:DMTK) Dividends: History, Yield and DatesJanuary 3, 2024 | benzinga.comDERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmDecember 29, 2023 | businesswire.comDMTK DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action ...December 15, 2023 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DermTech, Inc. (DMTK)December 14, 2023 | businesswire.comDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the ...December 13, 2023 | businesswire.comINVESTOR ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action LawsuitDecember 13, 2023 | markets.businessinsider.comDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the FirmDecember 12, 2023 | financialpost.comFDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the FirmDecember 12, 2023 | businesswire.comDermTech Ongoing Deadline AlertDecember 12, 2023 | markets.businessinsider.comIMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses to Contact the FirmDecember 11, 2023 | barrons.comSHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of DermTech, Inc. (DMTK) of a Class Action Lawsuit and an Upcoming DeadlineDecember 7, 2023 | barrons.comDermTech Deadline AlertDecember 6, 2023 | stockhouse.comROSEN, A RANKED AND LEADING FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMTKDecember 2, 2023 | barrons.comROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMTKNovember 29, 2023 | benzinga.comDMTK Investor Alert: Bronstein, Gewirtz & Grossman LLC Reminds DermTech, Inc. Investors with Substantial Losses to Contact the Firm!November 29, 2023 | barrons.comLawsuit Deadline Alert: Investors who lost over $100,000 with shares of DermTech, Inc. (NASDAQ: DMTK) should contact the Shareholders FoundationNovember 28, 2023 | benzinga.comSHAREHOLDER ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action LawsuitNovember 26, 2023 | markets.businessinsider.comDMTK Investors Have Opportunity to Lead DermTech, Inc. Securities Fraud LawsuitNovember 22, 2023 | benzinga.com Get DermTech News Delivered to You Automatically Sign up to receive the latest news and ratings for DMTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DMTK Media Mentions By Week DMTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DMTK News Sentiment▼0.000.71▲Average Medical News Sentiment DMTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DMTK Articles This Week▼00▲DMTK Articles Average Week Get the Latest News and Ratings for DMTK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for DermTech and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BioNexus Gene Lab News SunLink Health Systems News Aclarion News ATI Physical Therapy News VSee Health News NewGenIvf Group News Ontrak News IMAC News Aclarion News American Oncology Network News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DMTK) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DermTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DermTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
